Value Bridge — LOGAN HEALTH WHITEFISH
Current $14M → Target $16M (+$2.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$14.0M
Current EBITDA
$16.3M
Target EBITDA
+$2.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.5M
Payer Mix Optimization
$1.2M
Cost to Collect Reduction
$0.4M
Clean Claim Improvement
$0.3M
Volume & Rate Growth
$2.0M
What This Means
The 7-lever model projects a 16% EBITDA uplift from $14M to $16M. The highest-impact lever is Volume & Rate Growth at $0.8M probability-weighted.
IC talking point: "We see $2M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $25M in equity value creation."